EMA Advisory Committee Recommends Approval of Lilly’s Cancer Drug
By

By
Eli Lilly and Company has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending the granting of a conditional marketing…

Janssen Gets Positive European Opinion for Crohn’s Disease Drug
By

By
Janssen-Cilag International, a Johnson & Johnson company, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommending marketing authorization…

Pfizer Gets Positive European Opinion for Breast Cancer Therapy
By

By
Pfizer has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommending marketing authorization approval of Ibrance (palbociclib) in the…

Shire Receives FDA Approval for Immunodeficiency Drug
By

By
Shire has received approval from the US Food and Drug Administration (FDA) for Cuvitru (immune globulin (IG) subcutaneous (human), 20% solution) in adult and pediatric patients two years of age…

Eisai’s Kisplyx Licensed for New Cancer Drug Indication
By

By
Eisai has received a license from the European Commission for the anti-cancer agent, Kisplyx (lenvatinib), in combination with everolimus for adult patients with advanced renal cell carcinoma following one prior…

Teva Launches Authorized Generic of Cubicin
By

By
Teva Pharmaceutical Industries has launched an authorized generic of Merck & Co.’s Cubicin (daptomycin for injection) 500 mg per vial, for treating adults with complicated skin and skin structure infections…

Pfizer, OncoImmune in Immuno-Oncology Licensing Pact
By

By
Pfizer has signed an exclusive option and license agreement with OncoImmune, a clinical-stage biopharmaceutical company based in Rockville, Maryland, for OncoImmune’s immuno-oncology drug candidate, ONC-392, a differentiated, preclinical anti-cytotoxic T-lymphocyte…

Pregis Acquires Easypack
By

By
Pregis, a Chicago-based packaging firm, has acquired Easypack, a paper-based protective packaging company based in Hertfordshire, UK, for an undisclosed amount. The acquisition will enable Pregis to expand its North…

Custom Pharma Services Adds New Location
By

By
Custom Pharma Services, a Hove, UK-based contract development and manufacturing organization for solid dose products, has acquired a new building to expand its high containment manufacturing and development operations. The…

AstraZeneca, Bespak in Supply Pact for Inhalers
By

By
AstraZeneca has formed a multi-year commercial supply agreement with Norfolk, UK-based Bespak, a Consort Medical company, for the scale-up and supply of Bespak’s proprietary pressurized metered dose inhaler valves and…